ANGIOTECH SHARES UP ON TAXUS REGISTRY DATA

Shares of Canada's Angiotech Pharmaceuticals Inc. rose Tuesday after its partner Boston Scientific Corp. said preliminary six-month registry data for its Taxus Express2 drug-coated heart stent confirmed previous safety data. The Houston Chronicle (http://www.chron.com/disp/story.mpl/ap/fn/3723623.html)